Select a relevant service

To better assist you with your request, please choose a research area provided by NGeneBioAI. In case you cannot find an exact match, simply select any service, and our concierge team will swiftly address it once your request has been submitted.

Biomarker Discovery

Identify a biomarker associated with disease progression of disease, effectiveness of therapy or diagnosis of disease or condition.
LCMS Analysis

Physically separate substances using liquid chromatography and mass spectrometry.
Predictive Biomarkers Discovery

Identify candidate biomarkers suggestive of a response to a treatment.
Diagnostic Biomarkers Discovery

Identify candidate biomarkers indicative of the presence of a disorder.
Proteomics

Do large-scale experimental analysis of proteins focused on understanding structure and function.
Prognostic Biomarkers Discovery

Identify candidate biomarkers representative of disease progression without treatment.
Pharmacodynamic Biomarkers Discovery

Identify candidate biomarkers indicative of the therapeutic outcome of a drug-target interaction.
Mass Spectrometry-Based Proteomics

Detect histone post-translational modifications (hPTMs), histone variants, and interactomes at chromatin regions.
LCMS/MS Analysis

Liquid chromatography–mass spectrometry is an analytical chemistry technique that combines the physical separation capabilities of liquid chromatography with the mass analysis capabilities of mass spectrometry.
Quantitative MS

Quantify small and large molecules in the pg/ml range
Load more services